Skip to main content
Cytek Biosciences, Inc. logo

Cytek Biosciences, Inc. — Investor Relations & Filings

Ticker · CTKB ISIN · US23285D1090 LEI · 549300K2J28BOC6FBO89 US Manufacturing
Filings indexed 412 across all filing types
Latest filing 2023-05-11 Director's Dealing
Country US United States of America
Listing US CTKB

About Cytek Biosciences, Inc.

https://cytekbio.com

Cytek Biosciences, Inc. is a cell analysis solutions company that provides instruments, reagents, and services based on its patented Full Spectrum Profiling (FSP) technology. This technology enables its flow cytometry systems, including the Aurora, Northern Lights, and Muse series, to capture the entire emission spectrum of fluorescent dyes. This allows researchers to conduct high-resolution, high-multiplex experiments, using panels of 40 or more colors from a single sample. By providing more data from precious samples, the technology aims to reduce experimental complexity and cost. Cytek offers a complete solution with its cFluor® reagents, which are optimized for spectral cytometry, alongside software and application support. The company's products are intended to advance biomedical research in fields such as immunology, cancer research, and cell biology.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2023-05-11 English
10-Q
Interim / Quarterly Report Q1 2023
2023-05-09 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 9, 2023, reporting the issuance of a press release announcing financial results for the quarter ended March 31, 2023. The text explicitly states that the press release is furnished as an exhibit and that the information is being "furnished" rather than "filed." The document itself does not contain detailed financial statements or substantive financial data but rather announces the release of such information. The length is 3321 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a current report announcing the earnings release but not the earnings release itself.
2023-05-09 English
Regulatory Filings 2023
Regulatory Filings
2023-05-08 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-05-05 English
FORM ARS
Annual Report
2023-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.